ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, presenting promising advancements across a variety of healthcare and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA provides a safer, additional responsible option for the